Skip to main content

Table 1 Postpartum contraception receipt after delivery stratified by buprenorphine (BUP) versus psychosocial services without medication (PSY)

From: Buprenorphine and postpartum contraception utilization among people with opioid use disorder: a multi-state analysis

 

Overall

PSY, N(%)

BUP, N(%)

P-value

  

7,675 (69.0)

3,443 (31.0)

 

Age, mean (SD)

28.5 (4.8)

28.6 (4.7)

28.4 (4.8)

0.05

Age, Under 30 vs. ≥ 30

6,718 (60.4)

4,599 (59.9)

2,119 (61.6)

0.11

Race/Ethnicity

    

 Missing

832 (7.5)

474 (6.2)

358 (10.4)

< 0.001

 Non-Hispanic White

9,049 (81.4)

6,442 (83.9)

2,607 (75.7)

 

 Non-Hispanic Black

766 (6.9)

558 (7.3)

208 (6.0)

 

 Hispanic

187 (1.7)

81 (1.1)

106 (3.1)

 

 Other

284 (2.6)

120 (1.6)

164 (4.8)

 

Contraception Characteristics

Any Contraception at 90 days Postpartum

2,487 (22.4)

1,649 (21.5)

838 (24.3)

< 0.001

Contraception Subtypes at 90 days

   

< 0.001

Prescription (effective)

    

 Patch

25 (0.2)

8 (0.1)

17 (0.5)

 

 Ring

118 (1.1)

41 (0.5)

77 (2.2)

 

 Oral contraceptive pills

213 (1.9)

71 (0.9)

142 (4.1)

 

Provider-Administered (effective)

    

 Injection

430 (3.9)

324 (4.2)

106 (3.1)

 

Provider-Administered (highly effective)

    

 Long-acting reversible contraception

1,022 (9.2)

734 (9.6)

288 (8.4)

 

 Female sterilization

679 (6.1)

471 (6.1)

208 (6.0)

 

Co-Occurring Conditions

Alcohol Use Disorder

1,115 (10.0)

894 (11.7)

221 (6.4)

< 0.001

Stimulant Use Disorder

2,845 (25.6)

2,244 (29.2)

601 (17.5)

< 0.001

Sedative Use Disorder

839 (7.6)

639 (8.3)

200 (5.8)

< 0.001

Anxiety Disorder

4,369 (39.3)

3,193 (41.6)

1,176 (34.2)

< 0.001

Mood Disorder

4,155 (37.4)

3,076 (40.1)

1,079 (31.3)

< 0.001

Insomnia

534 (4.8)

404 (5.3)

130 (3.8)

< 0.001

Migraine

395 (3.6)

289 (3.8)

106 (3.1)

< 0.001

Chronic Pain

568 (5.1)

350 (4.6)

218 (6.3)

< 0.001